Joint Stock Co Pharmstandard Public, 10% Owner at ARGOS THERAPEUTICS INC (ARGS), bought 83,080 shares at $4.70 ($391K) on 2016-10-03, disclosed to the SEC on 2016-10-04.
Open-market purchase of $391k ARGS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.71 | 30,232 | $142K | 36.4% |
| 2 | $4.71 | 30,232 | $142K | 36.4% |
| 3 | $4.70 | 11,308 | $53K | 13.6% |
| 4 | $4.70 | 11,308 | $53K | 13.6% |
| Total | $4.71 avg | 83,080 | $391K | 100% |
| Filing → |
| ARGS | BUY | 2016-09-20 | $501K | — | Filing → |
| ARGS | BUY | 2016-08-25 | $305K | — | Filing → |
| PRTO | BUY | 2014-10-29 | $6.0M | — | Filing → |